Generate:Biomedicines

Earlier this week, JEOL Ltd. President and CEO Izumi Oi stopped by our state-of-the-art #CryoEM facility in Andover, Massachusetts – getting a firsthand look at how we're leveraging this technology to revolutionize drug discovery and development. JEOL is a world leader in CryoEM, and we're excited that our Andover laboratory is equipped with their cutting-edge electron microscopes.    Check out a picture from the visit below 👇, which features members of our CryoEM team – including Edward Brignole, Rajeev Chaudhary, Joseph G., Tristan Bell and Patricia Feliciano.    #GenerativeBiology I #ProtienEngineering 

Situated in Massachusetts’ esteemed biotech landscape, known for its dedication to education and proactive policymaking, #TeamGenerate is leading the way in applying #AI to revolutionize drug development. We are harnessing #AI to swiftly and precisely develop better, novel medicines, demonstrated by our rapid 17-month progression from concept to clinic for a COVID-19 prophylactic. Leveraging this breakthrough, The Generate Platform is also targeting previously untreatable challenges in immunology and oncology, promising revolutionary, life-saving therapies. Want to join us on our journey? https://lnkd.in/gv9Ve3fd https://lnkd.in/ewUErpXH #GenerativeBiology | #FlagshipFounded

Next week, Dinesh De Alwis, PhD, Senior Vice President of Clinical Drug Development, will join Certara’s inaugural Certainty event in Philadelphia. This unique event invites industry leaders to discuss the latest innovations that will bring us closer to “certainty” in drug development.     Dinesh will join a panel discussion about the potential of model-informed drug development (MIDD) to accelerate each phase of the process. Alongside fellow panelists Lisa Hendricks of Novartis and John Davis of Regeneron, Dinesh will share how we’re leveraging MIDD to maximize efficiency and precision across the development continuum.     Learn more about the panel, which will be moderated by Karen Rowland Yeo and Mirjam Trame of Certera. https://lnkd.in/dReXZyVt    #GenerativeBiology I #GenerativeAI

May is #NationalBikeMonth. Whether you’re riding for fun, fitness, or essential trips, you are part of a national movement for safer streets, connected communities, and a healthier planet.      We’re thrilled to support our diverse community of bikers by offering tailored benefits and building amenities to enhance their cycling experience.     Are you ready to join the ride? Explore how our #FiercelyUnited culture could be your next destination.    https://lnkd.in/gKaKkEGJ 

One week later, we’re still buzzing from our feature on 60 MINUTES, spotlighting our #AI-driven approach that’s revolutionizing drug development. Kudos to Alexandra Snyder, MD and everyone at #TeamGenerate for an outstanding demonstration of our work. Last week’s Generate Awards ceremony saw Amy DeZenzo recognized for Stunt Coordination, a testament to her dedication and our #FiercelyUnited culture. Amy, along with the efforts of so many Generators, truly showcases the teamwork that fuels our mission to improve human health. We’re not just innovating; we’re transforming healthcare. Inspired to be part of this revolution? Explore our career opportunities and help shape the future of medicine: https://lnkd.in/gKaKkEGJ #GenerativeBiology | #ProteinEngineering

On May 3, Ilja Kuesters from our Assay Automation & Qualification team will join world-class scientific leaders at the 23rd Annual Drug Discovery Innovation Programme (DDIP), where he will speak about the transformational role of #GenerativeAI in drug development.     ◾11:55am ET Presentation: “Streamlining Drug Development with Integrated Labs, Automation, And Machine Learning.”  ◾ 3:00pm ET Interactive Panel: “Harnessing #ArtificialIntelligence in Drug Discovery: Strategies, Challenges, And Future Directions.” This session will feature moderator Istvan Enyedy of UCB and panelists Alexandra Joseph of Exo Therapeutics, Xingfeng Bao of GV20 Therapeutics, and G. Joseph Franklin of Anagenex.      Don't miss this opportunity to discover how #AI and #ML are ushering in a new era for healthcare. https://lnkd.in/eSnaJstM    #GenerativeAI |#DDIP24 

Last week, we had the privilege of hosting the NESBA CryoEM Mini Symposia, spotlighting the cutting-edge CryoEM work happening in healthcare. This event brought together leaders in the field to discuss the present and future potential of CryoEM technology in scientific advancement.    The event included our very own Head of CryoEM Edward Brignole, and distinguished speakers Min Woo Sung, Andrey M., Sandra Gabelli, Charles Sindelar, Claudio Catalano, and Maria Vicente Carreira.    Our CryoEM facility in Andover is pushing the boundaries of how biological molecules are visualized, enhancing our ability to develop novel therapeutics. The discussion and insights shared at this symposium underscore our commitment to leading innovation in structural biology.    #GenerativeAI | #ProteinEngineering  

We are proud to announce Lisa Wyman's promotion to Chief Technical Operations Officer. Previously our Senior Vice President of Technical Operations, Lisa's new role now includes leading our Digital organization. This expansion reflects our commitment to integrating advanced digital technologies with our pioneering work in #GenerativeAI.     Click here to learn more: https://lnkd.in/e22f_VRR    #IntrinsicallyDigital | #WomenInSTEM 

We are thrilled to welcome Kym White as our new Chief Corporate Affairs Officer. With a deep background in healthcare, Kym brings her experience in shaping communications, public policy, and stakeholder engagement campaigns to #TeamGenerate. Her expertise in these areas will further our ability to communicate the promise of #AI and #GenerativeBiology to advance human health.     Click here to learn more: https://lnkd.in/dm5aeTBG #FiercelyUnited | #WomenInSTEM

Last night on 60 MINUTES, Alexandra Snyder, MD, our EVP of R&D, sat down with Bill Whitaker to share our patient-first approach to healthcare: “We’re taking what’s known and we’re really pushing the field; we’re pushing the biology to make drugs that look like regular drugs, but function even better.”    Discover how we’re harnessing #AI to instantly generate optimal therapeutics, aiming for the greatest impact on human health.    https://lnkd.in/ebSqSawE    #GenerativeAI | #ProteinEngineering